In order to help young members offset expenses to attend our Congress in Seoul, TTS 2020 will be offering Young Investigator Awards and International Transplantation Science Mentee-Mentor Awards. Award recipients will be selected on scientific merits (abstract submission deadline February 18, 2020).
To be eligible for the Young Investigator Awards, you need to apply by March 23, 2020, submit an abstract to the Congress, be a trainee (within 2 years of completion of their training and/or fellowship) and be a member of TTS.
TTS in collaboration with National and International Societies acknowledges the contribution of basic science to the field of transplantation by offering Mentee-Mentor awards.
To be eligible, you need to apply by March 23, 2020, submit an abstract to the Congress, be a graduate student or trainee (within 5 years of receiving PhD, MD), both Mentee and Mentor must attend TTS 2020 and be member of both TTS and confirmed supporting Societies.
With the February 2020 issue, Transplantation Direct begins its 6th full year of publishing articles on a monthly basis in the field of transplantation. Indeed, this issue offers a wide variety of clinical and experimental articles across different topics. In kidney transplantation, we have a comprehensive review on the newest information regarding cost-effectiveness of transplantation versus dialysis. Studies on using glucagon-like peptide-1 receptor agonists in recipients with type 2 diabetes to reduce insulin requirements, on use of MMF monotherapy in HLA-matched donor-recipients and on posttransplant emotional adjustments for Asian (especially younger) patients are presented. In the area of liver transplantation we have an experimental study of the effects of different biliary reconstruction methods on factors such as cholangitis and liver regeneration, and we offer clinical reports on once versus twice daily tacrolimus use on transplant outcomes and renal function, and for anesthesiologists there is a report on using transesophageal echocardiography and pulmonary artery catheterization to improve transplant outcomes. In the area of lung transplantation there is a report on an association of Anellovirus levels with primary graft dysfunction. Regarding intestinal transplantation, interesting results from off-label treatment with Vedolizumab (47 integrin-specific antibody) for cellular rejection are reported. These articles are available to everyone by open-access via the Transplantation Direct website - please visit us online!
The IPTA Outreach Committee is pleased to announce that applications for the 2020 Outreach Program are open. The program supports emerging centres that seek to develop or expand/enhance care in existing transplant programs.
Usually, an emerging centre will have identified a suitable supporting centre to assist them with this program; however it is possible the Outreach Committee can assist in this process.
The application package, guidelines and useful reference documents are available on the Outreach Program section of the IPTA website.
With many thanks,
Chair, IPTA Outreach Committee
In 2020, three Officer positions will be vacated and 7 of the 12 Councilors-at-large representing the Regions will be changing. The elections will take place early in 2020 and those elected will assume their new roles starting at the 2020 TTS Congress in Seoul.
Members can access the online nominating form at www.tts.org/nominations. Since each nominee must have his or her form signed by three supporting members (including him/herself), the online process allows for efficient and rapid circulation.
For more information on elections, visit the TTS website and consult the By-Laws in the “About” section.
If you were unable to participate in the TTS-STALYC Interactive Update Course, TTS and Sections Members can access the course recordings in the TTS Educational Library in English, Spanish and Portuguese!
Dr. Karen Keung, Editorial Fellow, Transplantation
Adam R, Karam V, Cailliez V, et al.
Transplantation: September 2019 - Volume 103 - Issue 9 - p 1844-1862
Reducing nonadherence to immunosuppressant medication and decreasing intrapatient variability in tacrolimus exposure in liver transplantation have been reported as advantages of once daily prolonged release tacrolimus (PR-T) over twice daily immediate release tacrolimus (IR-T). In this retrospective analysis using data from the European Liver Transplant Registry, Adam et al compared the graft outcomes of primary liver transplant recipients on PR-T versus IR-T. This was an extension of a previously published study (with 4367 patients) by this group.
13 088 patients transplanted between 2008 to 2016 were included from 44 European centers; propensity score-matched analyses comprised 3006 patients (PR-T to IR-T in a 1:2 ratio). Kaplan-Meier analysis demonstrated significantly improved graft and patient survival over 4 years with PR versus IR tacrolimus (83% versus 77%; P = 0.005 and 85% versus 80%; P = 0.017, respectively). Patients converted from IR-T to PR-T after 1 month also had a significantly higher graft and patient survival rates, compared with patients who were started on and still receiving PR tacrolimus at the last follow-up.
These results were consistent with the findings in their initial study and supports the use of PR-T over IR-T in liver transplant recipients.
Jan. 30 - Three-dimensional printers have now assembled candy, clothing, and even mouse ovaries. But in the next decade, specialized bioprinters could begin to build functioning human organs in space. It turns out, the minimal gravity conditions in space may provide a more ideal environment for building organs than gravity-heavy Earth.
Jan. 31 - Virtual antibody crossmatching is a safe and efficient way of selecting kidney transplant recipients. Two years after implementing the process, the Medical University of South Carolina (MUSC) division of transplant surgery, Charleston, concluded that the technique was just as accurate and sensitive as physical crossmatch, the current gold standard, and much quicker.
Jan. 30 - For patients undergoing living kidney transplants, persistent mixed chimerism can be achieved to allow complete or partial withdrawal of immunosuppressive drugs, according to a study published in the Jan. 29 issue of Science Translational Medicine.
Jan. 30 - Until very recently, hearts from donors testing positive for the hepatitis C virus (HCV) were seen as too risky to be used in transplantation. Doctors were fearful of introducing a new virus into the system of a patient already burdened with poor health, leading to a dearth of usable hearts and a long wait list. But a study recently published in the Journal of the American Heart Associationrevealed that using hearts from HCV-positive donors poses no unusual risk to recipients by the 1-year anniversary of transplantatio
Feb. 1 - A team of researchers at the Westmead Institute for Medical Research, in New South Wales, Australia, has established a technique for helping to improve transplant outcomes for patients with diabetes undergoing islet transplantation.
We are excited to announce that the planning for the Chauvet 2020 meeting is well underway. This meeting is of interest to all health care providers who care for individuals with upper extremity amputations, severe facial disfigurement, absolute uterine factor infertility and those with loss of laryngeal function and all VCA candidates and recipients. If you are in any discipline with an interest in the psychosocial aspects of these patients, this meeting will interest you.
Watch for links to more information coming soon!
The Transplantation Society
505 Boulevard René-Lévesque Ouest
Montréal, QC, H2Z 1Y7